Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 2,970.00
+75.00 (2.59%)
Jan 27, 2026, 4:51 PM GMT
Genus Market Cap
Genus has a market cap or net worth of 1.99 billion as of January 27, 2026. Its market cap has increased by 112.45% in one year.
Market Cap
1.99B
Enterprise Value
2.21B
Revenue
672.80M
Ranking
n/a
PE Ratio
102.77
Stock Price
2,970.00
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 1.99B, an increase of 6,304.41%. That is a compound annual growth rate of 16.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 1.94B | 11.56% |
| Dec 31, 2025 | 1.74B | 70.54% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.65B |
| Oxford Biomedica | 1.05B |
| PureTech Health | 325.31M |
| Avacta Group | 238.39M |
| Faron Pharmaceuticals Oy | 198.16M |
| Scancell Holdings | 136.99M |
| Bioventix | 91.44M |
| 4basebio | 89.00M |